This article reviews the impact of bipolar disorder on the quality of life of affected individuals. In particular, the impact of atypical antipsychotics on the quality of life of individuals with bipolar disorder is addressed. Among atypical antipsychotics, olanzapine has been studied most with regard to quality of life. In general, symptomatic improvements have been associated with improvements in quality of life.
|Original language||English (US)|
|Journal||American Journal of Managed Care|
|Issue number||SUPPL. 9|
|State||Published - Oct 1 2005|
ASJC Scopus subject areas
- Health Policy